Search results
Prometheus Biosciences, Inc. (RXDX) is a Great Momentum Stock: Should You Buy?
Zacks via Yahoo Finance· 1 year agoMomentum investing revolves around the idea of following a stock's recent trend in either direction....
Wall Street Analysts Think Prometheus Biosciences, Inc. (RXDX) Could Surge 33.49%: Read This Before...
Zacks via Yahoo Finance· 1 year agoThe mean of analysts' price targets for Prometheus Biosciences, Inc. (RXDX) points to a 33.5% upside...
What Makes Prometheus Biosciences (RXDX) an Attractive Investment Choice?
Insider Monkey via Yahoo Finance· 12 months agoBaron Funds, an investment management company, released its “Baron Health Care Fund” first quarter...
Positive Clinical Trial Results Pushed Prometheus Biosciences (RXDX) in Q4
Insider Monkey via Yahoo Finance· 1 year agoAlger Capital, an investment management company, released its “Alger Small Cap Focus Fund” fourth...
Prometheus Bio 'Comfortably Overshoots' Drug's Expectations — And Shares Nearly Triple
Investor's Business Daily· 1 year agoPrometheus Biosciences reported promising results for one of its drugs in two inflammatory disease...
Merck Nabs Prometheus Bio For $10.8 Billion As Keytruda Patent Expirations Loom
Investor's Business Daily· 1 year agoMerck is acquiring immunology-focused drugmaker Prometheus Bio in a well-timed $10.8 billion deal...
Prometheus Biosciences, Inc. (RXDX) Stock Jumps 69.7%: Will It Continue to Soar?
Zacks via Yahoo Finance· 1 year agoPrometheus Biosciences, Inc. (RXDX) was a big mover last session on higher-than-average trading...
Prometheus Biosciences (NASDAQ:RXDX) pulls back 15% this week, but still delivers shareholders...
Simply Wall St. via Yahoo Finance· 2 years agoIt's been a soft week for Prometheus Biosciences, Inc. (NASDAQ:RXDX) shares, which are down 15%. But...
Prometheus Biosciences, Inc. (RXDX) Reports Q2 Loss, Tops Revenue Estimates
Zacks via Yahoo Finance· 2 years agoPrometheus Biosciences, Inc. (RXDX) delivered earnings and revenue surprises of 6.52% and 81.29%,...
What Makes Prometheus Biosciences, Inc. (RXDX) a New Buy Stock
Zacks via Yahoo Finance· 2 years agoPrometheus Biosciences, Inc. (RXDX) might move higher on growing optimism about its earnings...